Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,144,000
-$6,376,000 QoQ
Shares Held
200,000
-66.7% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#63
of 290 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MASTERS CAPITAL MANAGEMENT LLC holds $17,438,000 across 2 Biotechnology names. DNLI ranks #2 (29.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MANE |
Veradermics, Inc
|
100,000 | $12,294,000 | |
| 2 | DNLI |
Denali Therapeutics Inc.
This page
|
200,000 | $5,144,000 |
All Filings in DNLI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,144,000 | 200,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,520,000 | 600,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,510,000 | 1,000,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,890,000 | 750,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,394,000 | 600,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||